Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Meta-Analysis
. 2013 May 31;2013(5):CD005229.
doi: 10.1002/14651858.CD005229.pub3.

Therapeutic exercise for people with amyotrophic lateral sclerosis or motor neuron disease

Affiliations
Meta-Analysis

Therapeutic exercise for people with amyotrophic lateral sclerosis or motor neuron disease

Vanina Dal Bello-Haas et al. Cochrane Database Syst Rev. .

Abstract

Background: Despite the high incidence of muscle weakness in individuals with amyotrophic lateral sclerosis (ALS) or motor neuron disease (MND), the effects of exercise in this population are not well understood. This is an update of a review first published in 2008.

Objectives: To systematically review randomised and quasi-randomised studies of exercise for people with ALS or MND.

Search methods: We searched The Cochrane Neuromuscular Disease Group Specialized Register (2 July 2012), CENTRAL (2012, Issue 6 in The Cochrane Library), MEDLINE (January 1966 to June 2012), EMBASE (January 1980 to June 2012), AMED (January 1985 to June 2012), CINAHL Plus (January 1938 to June 2012), LILACS (January 1982 to June 2012), Ovid HealthSTAR (January 1975 to December 2012). We also searched ProQuest Dissertations & Theses A&I (2007 to 2012), inspected the reference lists of all papers selected for review and contacted authors with expertise in the field.

Selection criteria: We included randomised or quasi-randomised controlled trials of people with a diagnosis of definite, probable, probable with laboratory support, or possible ALS, as defined by the El Escorial criteria. We included progressive resistance or strengthening exercise, and endurance or aerobic exercise. The control condition was no exercise or standard rehabilitation management. Our primary outcome measure was improvement in functional ability, decrease in disability or reduction in rate of decline as measured by a validated outcome tool at three months. Our secondary outcome measures were improvement in psychological status or quality of life, decrease in fatigue, increase in, or reduction in rate of decline of muscle strength (strengthening or resistance studies), increase in, or reduction in rate of decline of aerobic endurance (aerobic or endurance studies) at three months and frequency of adverse effects. We did not exclude studies on the basis of measurement of outcomes.

Data collection and analysis: Two review authors independently assessed trial quality and extracted the data. We collected adverse event data from included trials. The review authors contacted the authors of the included studies to obtain information not available in the published articles.

Main results: We identified two randomised controlled trials that met our inclusion criteria, and we found no new trials when we updated the searches in 2012. The first, a study with overall unclear risk of bias, examined the effects of a twice-daily exercise program of moderate load endurance exercise versus "usual activities" in 25 people with ALS. The second, a study with overall low risk of bias, examined the effects of thrice weekly moderate load and moderate intensity resistance exercises compared to usual care (stretching exercises) in 27 people with ALS. After three months, when the results of the two trials were combined (43 participants), there was a significant mean improvement in the Amyotrophic Lateral Sclerosis Functional Rating Scale (ALSFRS) measure of function in favour of the exercise groups (mean difference 3.21, 95% confidence interval 0.46 to 5.96). No statistically significant differences in quality of life, fatigue or muscle strength were found. In both trials adverse effects, investigators reported no adverse effects such as increased muscle cramping, muscle soreness or fatigue

Authors' conclusions: The included studies were too small to determine to what extent strengthening exercises for people with ALS are beneficial, or whether exercise is harmful. There is a complete lack of randomised or quasi-randomised clinical trials examining aerobic exercise in this population. More research is needed.

PubMed Disclaimer

Conflict of interest statement

VDBH and JMF are co‐investigators of one of the included randomised trials. VDBH received a grant from the Amyotrophic Lateral Sclerosis Association to conduct the study.

JMF has an interest in the design & implementation of outcome measures for clinical trials in neuromuscular disorders. She has been involved in this arena through her appointment in the Department of Neurology at Washington University School of Medicine in St. Louis and in the position of a consultant for several biotech, biomedical & pharmaceutical companies.

Figures

1
1
Risk of bias summary: review authors' judgements about each risk of bias item for each included study.
1.1
1.1. Analysis
Comparison 1 Exercise versus usual care, Outcome 1 ALSFRS scores at 3 months.
1.2
1.2. Analysis
Comparison 1 Exercise versus usual care, Outcome 2 SF‐36 scores at 3 months.
1.3
1.3. Analysis
Comparison 1 Exercise versus usual care, Outcome 3 Physical Function (SF‐36) subscale scores at 3 months.
1.4
1.4. Analysis
Comparison 1 Exercise versus usual care, Outcome 4 Physical Role (SF‐36) subscale scores at 3 months.
1.5
1.5. Analysis
Comparison 1 Exercise versus usual care, Outcome 5 Bodily Pain (SF‐36) subscale scores at 3 months.
1.6
1.6. Analysis
Comparison 1 Exercise versus usual care, Outcome 6 General Health (SF‐36) subscale scores at 3 months.
1.7
1.7. Analysis
Comparison 1 Exercise versus usual care, Outcome 7 Vitality (SF‐36) subscale scores at 3 months.
1.8
1.8. Analysis
Comparison 1 Exercise versus usual care, Outcome 8 Social Function (SF‐36) subscale scores at 3 months.
1.9
1.9. Analysis
Comparison 1 Exercise versus usual care, Outcome 9 Emotional Role (SF‐36) subscale scores at 3 months.
1.10
1.10. Analysis
Comparison 1 Exercise versus usual care, Outcome 10 Mental Health (SF‐36) subscale scores at 3 months.
1.11
1.11. Analysis
Comparison 1 Exercise versus usual care, Outcome 11 Physical Health summary scores.
1.12
1.12. Analysis
Comparison 1 Exercise versus usual care, Outcome 12 Mental Health summary scores.
1.13
1.13. Analysis
Comparison 1 Exercise versus usual care, Outcome 13 FSS scores at 3 months.
1.14
1.14. Analysis
Comparison 1 Exercise versus usual care, Outcome 14 MMT scores at 3 months.
1.15
1.15. Analysis
Comparison 1 Exercise versus usual care, Outcome 15 MVIC Upper Extremity.
1.16
1.16. Analysis
Comparison 1 Exercise versus usual care, Outcome 16 MVIC Lower Extremity.

Update of

References

References to studies included in this review

Dal Bello‐Haas 2007 {published and unpublished data}
    1. Dal Bello‐Haas VP, Florence JM, Kloos AD, Scheirbecker J, Lopate G, Hayes SM, et al. A randomized controlled trial of resistance exercise in individuals with ALS. Neurology 2007;68(23):2003‐7. [PUBMED: 17548549] - PubMed
Drory 2001 {published and unpublished data}
    1. Drory VE, Goltsman E, Reznik JG, Mosek A, Korczyn AD. The value of muscle exercise in patients with amyotrophic lateral sclerosis. Journal of Neurological Sciences 2001;191(1‐2):133‐7. [PUBMED: 11677004] - PubMed

Additional references

Aitkens 1993
    1. Aitkens SG, McCrory MA, Kilmer DD, Bernauer EM. Moderate resistance exercise program: its effect in slowly progressive neuromuscular disease. Archives of Physical Medicine & Rehabilitation 1993;74(7):711‐5. - PubMed
Andres 1986
    1. Andres PL, Hedlund W, Finison L, Conlon T, Felmus M, Munsat TL, et al. Quantitative motor assessment in amyotrophic lateral sclerosis. Neurology 1986;36(7):937‐41. - PubMed
Appel 1987
    1. Appel V, Stewart SS, Smith G, Appel SH. A rating scale for amyotrophic lateral sclerosis: description and preliminary experience. Annals of Neurology 1987;22(3):328‐33. - PubMed
Bennett 1958
    1. Bennett RL, Knowlton GC. Overwork weakness in partially denervated skeletal muscle. Clinical Orthopaedics and Related Research 1958;12:22‐9. - PubMed
Bergner 1981
    1. Bergner M, Bobbitt RA, Carter WB, Gilson BS. The Sickness Impact Profile: development and final revision of a health status measure. Medical Care 1981;19(8):787‐805. - PubMed
Bohannon 1983
    1. Bohannon RW. Results of resistance exercise on a patient with amyotrophic lateral sclerosis. Physical Therapy 1983;63(6):965‐8. - PubMed
Brooks 2000
    1. Brooks BR, Miller RG, Swash M, Munsat TL, World Federation of Neurology Research Group on Motor Neuron Diseases. El Escorial revisited: revised criteria for the diagnosis of amyotrophic lateral sclerosis. Amyotrophic Lateral Sclerosis and Other Motor Neuron Disorders 2000;1(5):293‐9. - PubMed
Cedarbaum 1999
    1. Cedarbaum JM, Stambler N, Malta E, Fuller C, Hilt D, Thurmond B. The ALSFRS‐R: A revised ALS functional rating scale that incorporates assessments of respiratory function. BDNF ALS Study Group (Phase III). Journal of the Neurological Sciences 1999;169(1‐2):13‐21. - PubMed
CNTF 1996
    1. The ALS CNTF Treatment Study (ACTS) Phase I‐II Study Group. The amyotrophic lateral sclerosis functional rating scale: Assessment of activities of daily living in patients with amyotrophic lateral sclerosis. Archives of Neurology 1996;53(2):141‐7. - PubMed
Coble 1985
    1. Coble NO, Maloney FP. Interdisciplinary rehabilitation of multiple sclerosis and neuromuscular disorders. In: Maloney FP, Burks JS, Ringel SP editor(s). Effects of Exercise in Neuromuscular Disease. New York: JB Lippincott, 1985:228‐38.
Deforges 2009
    1. Deforges S, Branchu J, Biondi O, Grondard C, Pariset C, Lécolle S, et al. Motoneuron survival is promoted by specific exercise in a mouse model of amyotrophic lateral sclerosis. Journal of Physiology 2009;587(Pt 14):3561‐751. - PMC - PubMed
Einarsson 1991
    1. Einarsson G. Muscle conditioning in late poliomyelitis. Archives of Physical Medicine and Rehabilitation 1991;72(1):11‐4. - PubMed
Florence 1984
    1. Florence JM, Hagberg JM. Effects of training on the exercise response of neuromuscular disease patients. Medicine and Science in Sports and Exercise 1984;16(5):460‐5. - PubMed
Gubbay 1985
    1. Gubbay SS, Kahana E, Zilber N, Cooper G, Pintov S, Leibowitz Y. Amyotrophic lateral sclerosis: A study of its presentation and prognosis. Journal of Neurology 1985;232(5):295‐300. - PubMed
Hamida 2000
    1. Hamida MB, Hentati F. Juvenile amyotrophic lateral sclerosis. In: Brown R Jr, Meininger V, Swash M editor(s). Amyotrophic Lateral Sclerosis. London: Martin Dunitz Ltd, 2000:59‐79.
Haverkamp 1995
    1. Haverkamp LJ, Appel V, Appel SH. Natural history of amyotrophic lateral sclerosis in database population. Validation of a scoring system and a model for survival prediction. Brain 1995;118(Pt 3):707‐19. - PubMed
Higgins 2011
    1. Higgins JPT, Altman DG, Sterne JAC (editors). Chapter 8: Assessing risk of bias in included studies. In: Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions. Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011 Available from www.cochrane‐handbook.org.
Hillel 1989
    1. Hillel AD, Miller RM, Yorkston K, McDonald E, Norris FH, Konikow N. Amyotrophic Lateral Sclerosis Severity Scale. Neuroepidemiology 1989;8(3):142‐50. - PubMed
Jenkinson 1999a
    1. Jenkinson C, Fitzpatrick R, Brennan M, Bromberg M, Swash M. Evidence for the validity and reliability of the ALS assessment questionnaire: the ALSAQ‐40. Amyotrophic Lateral Sclerosis and Other Motor Neuron Disorders 1999;1(1):33–40. - PubMed
Jenkinson 1999b
    1. Jenkinson C, Fitzpatrick R, Brennan C, Bromberg M, Swash M. Development and validation of a short measure of health status for individuals with amyotrophic lateral sclerosis/motor neurone disease: the ALSAQ‐40. Journal of Neurology 1999;246(Suppl 3):16–21. - PubMed
Johnson 1971
    1. Johnson EW, Braddom R. Overwork weakness in facioscapulohumeral muscular dystrophy. Archives of Physical Medicine and Rehabilitation 1971;52(7):333‐6. - PubMed
Kaspar 2005
    1. Kaspar BK, Frost LM, Christian L, Umapathi P, Gafe FH. Synergy of insulin‐like growth factor‐1 and exercise in amyotrophic lateral sclerosis. Annals of Neurology 2005;57(5):649‐55. - PubMed
Kilmer 1994
    1. Kilmer DD, McCrory MA, Wright NC, Aitkens SG, Bernauer EM. The effect of a high resistance exercise program in slowly progressive neuromuscular disease. Archives of Physical Medicine and Rehabilitation 1994;75(5):560‐3. - PubMed
Kirkinezos 2003
    1. Kirkinezos IG, Hernandez D, Bradley WG, Moraes CT. Regular exercise is beneficial to a mouse model of amyotrophic lateral sclerosis. Annals of Neurology 2003;53(6):804‐7. - PubMed
Krupp 1989
    1. Krupp LB, LaRocca NG, Muir‐Nash J, Steinberg AD. The fatigue severity scale. Application to patients with multiple sclerosis and systemic lupus erythematosus. Archives of Neurology 1989;46(10):1121‐23. - PubMed
Kurtzke 1991
    1. Kurtzke JF. Risk factors in amyotrophic lateral sclerosis. Advances in Neurology 1991;56:245‐70. - PubMed
Lindeman 1995
    1. Lindeman E, Leffers P, Spaans F, Drukker J, Reuben J, Kerckhoffs M. Strength training in patients with myotonic dystrophy and hereditary motor and sensory neuropathy: a randomized clinical trial. Archives of Physical Medicine and Rehabilitation 1995;76(7):612‐20. - PubMed
Mahoney 2004
    1. Mahoney DJ, Rodriguez C, Devries M, Yasuda N, Tarnopolsky M. Effects of high‐intensity endurance exercise training in the G93A mouse model of amyotrophic lateral sclerosis. Muscle & Nerve 2004;29(5):656‐62. - PubMed
McCartney 1988
    1. McCartney N, Moroz D, Garner SH, McComas AJ. The effects of strength training in patients with selected neuromuscular disorders. Medicine and Science in Sports and Exercise 1988;20(4):362‐8. - PubMed
Milner‐Brown 1988
    1. Milner‐Brown HS, Miller RG. Muscle strengthening through high resistance weight training in patients with neuromuscular disorders. Archives of Physical Medicine and Rehabilitation 1988;69(1):14‐9. - PubMed
Mitsumoto 1998
    1. Mitsumoto H, Chad DA, Pioro EK. Clinical features: Signs and symptoms. In: Mitsumoto H, Chad DA, Pioro EK editor(s). Amyotrophic Lateral Sclerosis. Philadelphia: F.A. Davis Company, 1998:47‐64.
Mulder 1986
    1. Mulder DW, Kurland LT, Offord KP, Beard CM. Familial adult motor neuron disease: amyotrophic lateral sclerosis. Neurology 1986;36(4):511‐7. - PubMed
Norris 1974
    1. Norris FH Jr, Calanchini PR, Fallat RF, Panchari S, Jewett B. The administration of guanidine in amyotrophic lateral sclerosis. Neurology 1974;24(8):721‐8. - PubMed
Norris 1993
    1. Norris F, Shepherd R, Denys E, Mukai E, Elias L, Holden D. Onset, natural history and outcome in idiopathic adult motor neuron disease. Journal of the Neurological Sciences 1993;118(1):48‐55. - PubMed
Pinto 1999
    1. Pinto AC, Alves M, Nogueira A, Evangelista T, Carvalho J, Coelho A, et al. Can amyotrophic lateral sclerosis patients with respiratory insufficiency exercise?. Journal of the Neurological Sciences 1999;169(1‐2):69‐75. - PubMed
Pradas 1993
    1. Pradas J, Finison L, Andres PL, Thornell B, Hollander D, Munsat TL. The natural history of amyotrophic lateral sclerosis and the use of natural history controls in therapeutic trials. Neurology 1993;43(4):751‐5. - PubMed
RevMan 2012 [Computer program]
    1. The Nordic Cochrane Centre, The Cochrane Collaboration. Review Manager (RevMan). Version 5.2. Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration, 2012.
Ringel 1993
    1. Ringel SP, Murphy JR, Alderson MK, Bryan W, England JD, Miller RG, et al. The natural history of amyotrophic lateral sclerosis. Neurology 1993;43(7):1316‐22. - PubMed
Rowland 1982
    1. Rowland LP. Diverse forms of motor neuron disease. Advances in Neurology 1982;36:1‐13. - PubMed
Sanjak 1987
    1. Sanjak M, Reddan W, Brooks BR. Role of muscular exercise in amyotrophic lateral sclerosis. Neurology Clinics 1987;5(2):251‐68, vi. - PubMed
Schwab 1969
    1. Schwab R, England A. Projection technique for evaluating surgery in Parkinson's disease. In: Gillingham J, Donaldson I editor(s). Third Symposium on Parkinson's Disease. Edinburgh: Livingstone, 1969.
Sinaki 1978
    1. Sinaki M, Mulder DW. Rehabilitation techniques for patients with amyotrophic lateral sclerosis. Mayo Clinic Proceedings 1978;53(3):173‐8. - PubMed
Strickland 1996
    1. Strickland D, Smith SA, Dolliff G, Goldman L, Roelofs R. Physical activity, trauma, and ALS: a case‐control study. Acta Neurologica Scandinavica 1996;94(1):45‐50. - PubMed
Strong 1991
    1. Strong MJ, Hudson AJ, Alvord WG. Familial amyotrophic lateral sclerosis, 1850‐1989: A statistical analysis of the world literature. Canadian Journal of Neurological Sciences 1991;18(1):45‐58. - PubMed
Swash 2000a
    1. Swash M, Desai J. Motor neuron disease: classification and nomenclature. Amyotrophic Lateral Sclerosis and Other Motor Neuron Disorders 2000;1(2):105‐12. - PubMed
Swash 2000b
    1. Swash M. Clinical features and diagnosis of amyotrophic lateral sclerosis. In: Brown R Jr, Meininger V, Swash M editor(s). Amyotrophic Lateral Sclerosis. London: Martin Dunitz Ltd, 2000:3‐30.
van der Kooi 2011
    1. Voet NBM, Kooi EL, Riphagen II, Lindeman E, Engelen BGM, Geurts ACH. Strength training and aerobic exercise training for muscle disease. Cochrane Database of Systematic Reviews 2010, Issue 1. [DOI: 10.1002/14651858.CD003907.pub3] - DOI - PubMed
Veldink 2003
    1. Veldink JH, Bar PR, Joosten EAJ, Otten M, Wokke JHJ, Berg LH. Sexual differences in onset of disease and response to exercise in a transgenic model of ALS. Neuromuscular Disease 2003;13(9):737‐43. - PubMed
Vignos 1983
    1. Vignos PJ Jr. Physical models of rehabilitation in neuromuscular disease. Muscle & Nerve 1983;6(5):323‐38. - PubMed
Ware 1993
    1. Ware JE, Snow KK, Kosinski M, Gandek B. SF‐36 Health Survey: Manual and Interpretation Guide. Boston: Health Institute, New England Medical Center, 1993.

References to other published versions of this review

Dal Bello‐Haas 2005
    1. DalBello‐Haas V, Florence J, Krivickas L. Therapeutic exercise for people with amyotrophic lateral sclerosis/motor neuron disease. Cochrane Database of Systematic Reviews 2005, Issue 2. [DOI: 10.1002/14651858.CD005229] - DOI - PubMed
Dal Bello‐Haas 2008
    1. Dal Bello‐Haas V, Florence JM, Krivickas LS. Therapeutic exercise for people with amyotrophic lateral sclerosis or motor neuron disease. Cochrane Database of Systematic Reviews 2008, Issue 2. [DOI: 10.1002/14651858.CD005229.pub2] - DOI - PMC - PubMed

MeSH terms